Apple and OpenEvidence Launch Study App to Examine AI Use in Health

Apple and OpenEvidence Launch Study App to Examine AI Use in Health

Apple Introduces a Research App to Track How Americans Use AI for Health Queries

Apple has begun a new research initiative aimed at understanding how people interact with artificial‑intelligence tools for health‑related information. According to TechCrunch, the iPhone maker is partnering with the healthcare‑focused AI company OpenEvidence to launch a study‑oriented app that will be available to U.S. users starting today.

The program targets adults over the age of 21 who own an iPhone 15 or later running iOS 26 or later with Apple Intelligence enabled. Apple plans to enroll up to 200,000 participants for a period that will extend beyond 12 months, allowing the company to gather longitudinal data on AI‑driven health interactions.

How the App Works

Participants can submit health‑related questions to the app in a manner similar to popular chatbots such as ChatGPT or Claude. As reported by TechCrunch, the responses are grounded in clinical data drawn from reputable sources, including The New England Journal of Medicine, the Journal of the American Medical Association, and Nature. Apple describes the answers as “simplified” to make everyday medical information more accessible.

After receiving a response, users are prompted to rate the answer and provide qualitative feedback. In addition, the study incorporates monthly surveys designed to capture participants’ perceptions, comprehension, and overall satisfaction with the AI‑generated information.

Integration With HealthKit

The app also offers an optional feature that lets participants share data from Apple’s HealthKit platform—such as resting heart rate, activity levels, sleep patterns, and lab results. According to TechCrunch, this data can be used to generate more personalized suggestions and to help users better prepare for upcoming medical appointments. The app may also direct users to specific healthcare providers when a query raises a potentially serious medical concern.

Data Privacy and Use

Apple emphasizes that all health data collected through the study will be anonymized before being transmitted to a secure third‑party cloud provider. The company states that the information will not be used to train any AI models. OpenEvidence, the partner firm, reportedly deletes query and response data after 24 hours, further limiting the retention of personally identifiable information.

Company Perspective

In a statement quoted by TechCrunch, Sumbul Desai, M.D., Apple’s vice president of Health and Fitness, said, “At Apple, we believe responsible innovation starts with scientific rigor and clinical grounding. Health is deeply personal, and conducting a dedicated research study is the most thoughtful way to understand how people engage with, comprehend, and evaluate health AI in everyday life.” She added that insights from the study will “help advance the broader scientific conversation and ensure that as technology evolves, we continue building trusted tools that genuinely support people wherever they are on their health journey.”

Context Within the AI‑Health Landscape

The launch arrives as other AI labs, such as OpenAI and Anthropic, have rolled out chatbots with specialized health‑answering capabilities. However, Apple’s approach, as described by TechCrunch, focuses on clinical grounding rather than the broader conversational models deployed by its competitors. The company has not indicated whether the findings will lead to the integration of AI‑driven answers into its Health app or Siri.

TechCrunch notes that earlier this year, OpenAI reported that users were asking over 300 million health‑related queries each week, underscoring the growing demand for AI‑based medical information. Apple’s study seeks to explore how accurate, evidence‑based AI responses might shape user behavior and health outcomes in this expanding market.

Potential Impact

If the study demonstrates that clinically sourced AI answers improve user understanding and health‑related decision‑making, Apple could leverage the findings to enhance its existing health ecosystem. Conversely, the research may reveal limitations or user concerns that could temper future AI deployments within Apple’s product suite.

Conclusion

Apple’s new partnership with OpenEvidence represents a structured effort to examine the role of AI in everyday health inquiries. By limiting participation to a defined U.S. demographic, enforcing strict data‑privacy safeguards, and anchoring responses in peer‑reviewed medical literature, the company aims to generate actionable insights about user engagement with health‑focused AI. The study will run for at least a year, with up to 200,000 participants contributing feedback, health data, and survey responses. As the AI‑health landscape continues to evolve, Apple’s research may inform both industry standards and the company’s own product roadmap.

Source: TechCrunch

Frequently Asked Questions

Who is eligible to join Apple’s AI health study?**

According to TechCrunch, the study is open to U.S. residents who are over 21 years old, own an iPhone 15 or later, run iOS 26 or later, and have Apple Intelligence enabled. **Q: What kind of medical sources does the app use for its answers?** A: The app’s responses are grounded in clinical data from sources such as The New England Journal of Medicine, the Journal of the American Medical Association, and Nature, as reported by TechCrunch. **Q: Will the data collected in the study be used to train Apple’s AI models?** A: TechCrunch states that Apple will anonymize the data and it will not be used to train any AI models. OpenEvidence also deletes query and response data after 24 hours.

Source: TechCrunch — Read more

💚 Related Articles